These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach. Jurcuţ C; Jurcuţ R; Tănăsescu C Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138 [TBL] [Abstract][Full Text] [Related]
24. Psoriasis: comorbidities and associations. Farley E; Menter A G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853 [TBL] [Abstract][Full Text] [Related]
25. [What are the risks of not intensively treating a chronic inflammatory disease?]. Goupille P Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S290-4. PubMed ID: 18721667 [TBL] [Abstract][Full Text] [Related]
26. [Patients with psoriasis have an increased risk of cardiovascular diseases]. Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk and psoriasis: the role of biologic therapy. Puig L Actas Dermosifiliogr; 2012 Dec; 103(10):853-62. PubMed ID: 23157913 [TBL] [Abstract][Full Text] [Related]
29. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities? Lotti T; Hercogova J; Prignano F Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818 [TBL] [Abstract][Full Text] [Related]
30. The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis. Benson MM; Frishman WH Cardiol Rev; 2015; 23(6):312-6. PubMed ID: 26440534 [TBL] [Abstract][Full Text] [Related]
31. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences. Boehncke WH Front Immunol; 2018; 9():579. PubMed ID: 29675020 [TBL] [Abstract][Full Text] [Related]
32. Comorbidities in patients with psoriasis. Gottlieb AB; Dann F Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894 [TBL] [Abstract][Full Text] [Related]
33. [Is psoriasis a dependent cardiovascular risk factor?]. Wakkee M; de Jong EM Ned Tijdschr Geneeskd; 2013; 157(11):A5417. PubMed ID: 23484510 [TBL] [Abstract][Full Text] [Related]
34. More than skin-deep: the many dimensions of the psoriatic disease. Boehncke WH; Boehncke S Swiss Med Wkly; 2014; 144():w13968. PubMed ID: 24764145 [TBL] [Abstract][Full Text] [Related]
35. Psoriasis: cardiovascular risk factors and other disease comorbidities. Wu Y; Mills D; Bala M J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519 [TBL] [Abstract][Full Text] [Related]
36. Psoriasis as a cardiovascular risk factor: updates and algorithmic approach. Cozzani E; Rosa GM; Burlando M; Parodi A G Ital Dermatol Venereol; 2018 Oct; 153(5):659-665. PubMed ID: 29683293 [TBL] [Abstract][Full Text] [Related]
37. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Cersosimo E; DeFronzo RA Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Johnsson H; McInnes IB; Sattar N Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk and psoriasis: beyond the traditional risk factors. Coumbe AG; Pritzker MR; Duprez DA Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194 [TBL] [Abstract][Full Text] [Related]